STAAR Surgical Co Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price
STAAR Surgical Co (STAA) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price of $15.93 per share for the 6-month period ending 2026-07-03, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice · last filed 2026-08-12
- STAAR Surgical Co share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2026-04-03 was $8.51, a 18.03% increase year-over-year.
- STAAR Surgical Co share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2025-03-28 was $7.21, a 74.70% decline year-over-year.
- STAAR Surgical Co share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2024-03-29 was $28.50.
- STAAR Surgical Co share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2026 was $15.66, a 33.42% decline from fiscal 2024.
- STAAR Surgical Co share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2024 was $23.52, a 25.98% increase from fiscal 2023.
- STAAR Surgical Co share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2023 was $18.67, a 5.28% decline from fiscal 2022.
- STAAR Surgical Co share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2022 was $19.71, a 22.27% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2026-07-03 | $15.93 10-Q · filed 2026-08-12 | |||
| 2026-04-03 | $8.51 10-Q · filed 2026-05-13 | |||
| 2026-01-02 | $15.66 10-K · filed 2026-03-03 | |||
| 2025-09-26 | $15.99 10-Q · filed 2025-11-05 | |||
| 2025-06-27 | $7.23 10-Q · filed 2025-08-06 | |||
| 2025-03-28 | $7.21 10-Q · filed 2025-05-07 | |||
| 2024-12-27 | $23.52 10-K · filed 2025-02-21 | |||
| 2024-09-27 | $23.76 10-Q · filed 2024-10-30 | |||
| 2024-06-28 | $27.83 10-Q · filed 2024-08-07 | |||
| 2024-03-29 | $28.50 10-Q · filed 2024-05-07 | |||
| 2023-12-29 | $18.67 10-K · filed 2024-02-27 | |||
| 2023-09-29 | $18.54 10-Q · filed 2023-11-06 | |||
| 2022-12-30 | $19.71 10-K · filed 2023-02-23 | |||
| 2021-12-31 | $16.12 10-K · filed 2022-02-23 | |||
| 2021-01-01 | $13.70 10-K · filed 2021-02-24 | |||
| 2020-01-03 | $8.92 10-K · filed 2020-02-26 | |||
| 2018-12-28 | $8.72 10-K · filed 2019-02-21 | |||
| 2017-12-29 | $7.12 10-K · filed 2018-02-28 | |||
| 2016-12-30 | $4.51 10-K · filed 2017-03-02 | |||
| 2016-01-01 | $4.56 10-K · filed 2016-03-11 | |||
| 2015-01-02 | $6.09 10-K · filed 2015-03-13 | |||
| 2014-01-03 | $5.10 10-K · filed 2014-03-12 | |||
| 2012-12-28 | $4.67 10-K · filed 2013-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| RxSight, Inc. (RXST) | United States | $0.197B | |
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |